Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
Roosenburg
Susan
S
Department of Nuclear Medicine, Radboud University Nijmegen Medical Center, The Netherlands.
Laverman
Peter
P
Joosten
Lieke
L
Eek
Annemarie
A
Oyen
Wim J G
WJ
de Jong
Marion
M
Rutjes
Floris P J T
FP
van Delft
Floris L
FL
Boerman
Otto C
OC
D000818:Animals; D002766:Cholecystokinin / Q000032:analysis / Q000737:chemistry* / Q000378:metabolism*; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes; D007553:Isotope Labeling; D051379:Mice; D008807:Mice, Inbred BALB C; D015394:Molecular Structure; D009369:Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D009942:Organometallic Compounds / Q000138:chemical synthesis* / Q000493:pharmacokinetics; D010084:Oxidation-Reduction; D010446:Peptide Fragments / Q000032:analysis / Q000737:chemistry* / Q000378:metabolism*; D051381:Rats; D043887:Receptor, Cholecystokinin B / Q000032:analysis / Q000378:metabolism*; D013237:Stereoisomerism; D014018:Tissue Distribution
D007205:Indium Radioisotopes; D009942:Organometallic Compounds; D010446:Peptide Fragments; D043887:Receptor, Cholecystokinin B; C410885:cholecystokinin 8; D002766:Cholecystokinin